PENTOXIFILIN-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, FOR TOPICAL APPLICATION, IN CREAM, GEL, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSULE FORM
    1.
    发明申请
    PENTOXIFILIN-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, FOR TOPICAL APPLICATION, IN CREAM, GEL, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSULE FORM 审中-公开
    基于PENTOXIFILIN的皮肤药理学组合物,用于局部应用,乳膏,凝胶,溶液,乳液,脂质体和微阵列

    公开(公告)号:US20110159077A1

    公开(公告)日:2011-06-30

    申请号:US12737961

    申请日:2009-08-25

    摘要: A pharmaceutical dermatological composition based on Pentoxifylline, to be applied on the skin in the form of a cream, gel, unguent, solution, in an emulsion, in liposomes and in microcapsules, being selective for the vascular disorders of rosacea and disorders with photosensitivity, reducing the blood vessels and the reactions of reddening of the skin, CHARACTERIZED in that said composition consists of: from 1% to 99% of Pentoxifylline, from 0.1% to 80% of base cream and from 0.1% to 75% of liposomes.

    摘要翻译: 一种基于己酮可可碱的药物皮肤病学组合物,其以霜剂,凝胶,无溶剂,乳剂,脂质体和微胶囊形式施用在皮肤上,对于红斑痤疮和具有光敏性的病症的血管疾病是有选择性的, 减少血管和皮肤红化的反应,其特征在于所述组合物由1%至99%的己酮可可碱,0.1%至80%的基础霜和0.1%至75%的脂质体组成。